Targeted Financial Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.52M Buy
6,042
+501
+9% +$108K 1.12% 16
2026
Q1
$1.21M Sell
5,541
-498
-8% -$110K 0.99% 17
2025
Q4
$1.38M Buy
+6,039
New +$1.38M 1.18% 15

Other funds holding ABBV

Targeted Financial Services's ABBV Position: Q2 2026 in Review

Targeted Financial Services increased its AbbVie (ABBV) stake by 9% in Q2 2026, buying an estimated $108K and bringing the position to 6,042 shares worth $1.52M. The position accounts for 1.12% of the portfolio, ranked #16.

Targeted Financial Services first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 4,187 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Targeted Financial Services held 6,042 shares of AbbVie worth $1.52M as of Q2 2026.
  • Targeted Financial Services bought 501 AbbVie shares in Q2 2026, an estimated $108K.
  • AbbVie made up 1.12% of Targeted Financial Services's portfolio in Q2 2026, its #16 holding.
  • Targeted Financial Services first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • 4,187 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Targeted Financial Services's 13F filing for Q2 2026, filed 16 Jul 2026.